[Form 4] RxSight, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider purchases reported for RxSight, Inc. (RXST). On 09/25/2025 Co-President and Chief Operating Officer Ilya Goldshleger acquired 15,096 and 8,349 shares of common stock at $4.34 and $4.13 per share respectively, increasing his direct holdings to 65,691 shares. Separate stock option exercises or grants totaling 23,445 options at $4.34 and $4.13 were also reported. Holdings include 1,372 shares held indirectly by spouse.

Positive

• Senior executive purchases shares on 09/25/2025, increasing direct holdings to 65,691 shares
• Acquisitions reported at clear prices of $4.34 and $4.13, providing transparent cost basis
• Stock option activity disclosed totaling 23,445 options across listed grant/exercise schedules
• Filing executed and signed by attorney-in-fact, meeting Section 16 disclosure requirements

Negative

• None.

Insights

Financial Analyst

TL;DR: Senior executive purchased shares and holds exercised options, signalling personal investment at modest prices.

These transactions show the COO increasing direct exposure through purchases and option activity on 09/25/2025. Total direct beneficial ownership after the trades is reported as 65,691 shares with an additional 1,372 shares held indirectly. The reported prices of $4.34 and $4.13 provide clear cost basis for the purchases. For investors, insider buying can be a signal of confidence but the absolute size should be compared to total outstanding shares to assess materiality.

Corporate Governance Expert

TL;DR: Filing is a routine Section 16 disclosure showing officer purchases and option transactions with full signature and remarks.

The Form 4 was properly executed by an attorney-in-fact and identifies the reporting person as Co-President and Chief Operating Officer. The report lists multiple non-derivative acquisitions and derivative option items, and discloses indirect ownership via spouse. The filing contains the required remarks and signature, fulfilling Section 16 reporting obligations. No amendments or additional regulatory notes are provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Goldshleger Ilya

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CA 92656

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		M		15,096	A	$4.34	57,342	D
Common Stock	09/25/2025		M		8,349	A	$4.13	65,691	D
Common Stock								1,372	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$4.34	09/25/2025		M			5,416	10/27/2020	10/26/2026	Common Stock	5,416	$0	0	D
Stock Option (right to buy)	$4.34	09/25/2025		M			9,680	02/24/2021	03/13/2027	Common Stock	9,680	$0	0	D
Stock Option (right to buy)	$4.13	09/25/2025		M			8,349	04/26/2021	04/25/2027	Common Stock	8,349	$0	12,494	D

Explanation of Responses:

Remarks:

Co-President and Chief Operating Officer

	/s/ Robert L. Wernli, Jr., as Attorney-in-Fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Ilya Goldshleger report for RXST?

On 09/25/2025 he reported acquiring 15,096 shares at $4.34 and 8,349 shares at $4.13, plus related option items.

How many RXST shares does the reporting person beneficially own after the transactions?

The report shows 65,691 shares owned directly following the reported transactions and 1,372 held indirectly by spouse.

Were any derivative securities reported in the Form 4 for RXST?

Yes. The filing lists stock options with strike prices of $4.34 and $4.13, totaling 23,445 options across listed grants.

Who signed the Form 4 for the reporting person?

The form was signed by Robert L. Wernli, Jr., as Attorney-in-Fact on behalf of the reporting person.

What is the reporting person’s role at RxSight?

The filing states the reporting person is Co-President and Chief Operating Officer.